nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CHRM2—Dimenhydrinate—atopic dermatitis	0.126	0.2	CbGbCtD
Paroxetine—CHRM2—Diphenhydramine—atopic dermatitis	0.0613	0.0978	CbGbCtD
Paroxetine—CYP2C8—Mometasone—atopic dermatitis	0.061	0.0973	CbGbCtD
Paroxetine—CYP2B6—Diphenhydramine—atopic dermatitis	0.0463	0.0738	CbGbCtD
Paroxetine—CYP2C8—Loratadine—atopic dermatitis	0.035	0.0559	CbGbCtD
Paroxetine—ABCB1—Tacrolimus—atopic dermatitis	0.0324	0.0517	CbGbCtD
Paroxetine—CYP2C9—Loratadine—atopic dermatitis	0.0244	0.039	CbGbCtD
Paroxetine—CYP2C9—Diphenhydramine—atopic dermatitis	0.0244	0.039	CbGbCtD
Paroxetine—ABCB1—Loratadine—atopic dermatitis	0.0237	0.0378	CbGbCtD
Paroxetine—CYP2D6—Loratadine—atopic dermatitis	0.0223	0.0356	CbGbCtD
Paroxetine—CYP2D6—Diphenhydramine—atopic dermatitis	0.0223	0.0356	CbGbCtD
Paroxetine—ABCB1—Methylprednisolone—atopic dermatitis	0.0217	0.0346	CbGbCtD
Paroxetine—CYP2C8—Hydrocortisone—atopic dermatitis	0.0195	0.0311	CbGbCtD
Paroxetine—CYP2B6—Dexamethasone—atopic dermatitis	0.016	0.0255	CbGbCtD
Paroxetine—ABCB1—Betamethasone—atopic dermatitis	0.0141	0.0225	CbGbCtD
Paroxetine—ABCB1—Prednisolone—atopic dermatitis	0.0139	0.0222	CbGbCtD
Paroxetine—ABCB1—Hydrocortisone—atopic dermatitis	0.0132	0.021	CbGbCtD
Paroxetine—ABCB1—Prednisone—atopic dermatitis	0.0131	0.021	CbGbCtD
Paroxetine—CYP2C8—Dexamethasone—atopic dermatitis	0.0121	0.0193	CbGbCtD
Paroxetine—CYP2C9—Dexamethasone—atopic dermatitis	0.00845	0.0135	CbGbCtD
Paroxetine—ABCB1—Dexamethasone—atopic dermatitis	0.0082	0.0131	CbGbCtD
Paroxetine—CYP2D6—Dexamethasone—atopic dermatitis	0.00773	0.0123	CbGbCtD
Paroxetine—Oedema—Hydrocortisone—atopic dermatitis	6.49e-05	0.000214	CcSEcCtD
Paroxetine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	6.49e-05	0.000214	CcSEcCtD
Paroxetine—Convulsion—Triamcinolone—atopic dermatitis	6.49e-05	0.000214	CcSEcCtD
Paroxetine—Tachycardia—Prednisolone—atopic dermatitis	6.49e-05	0.000214	CcSEcCtD
Paroxetine—Convulsion—Methylprednisolone—atopic dermatitis	6.47e-05	0.000213	CcSEcCtD
Paroxetine—Hypertension—Triamcinolone—atopic dermatitis	6.47e-05	0.000213	CcSEcCtD
Paroxetine—Hypertension—Methylprednisolone—atopic dermatitis	6.45e-05	0.000212	CcSEcCtD
Paroxetine—Infection—Hydrocortisone—atopic dermatitis	6.45e-05	0.000212	CcSEcCtD
Paroxetine—Hyperhidrosis—Prednisolone—atopic dermatitis	6.43e-05	0.000212	CcSEcCtD
Paroxetine—Shock—Hydrocortisone—atopic dermatitis	6.39e-05	0.00021	CcSEcCtD
Paroxetine—Myalgia—Triamcinolone—atopic dermatitis	6.38e-05	0.00021	CcSEcCtD
Paroxetine—Nervous system disorder—Hydrocortisone—atopic dermatitis	6.37e-05	0.00021	CcSEcCtD
Paroxetine—Arthralgia—Methylprednisolone—atopic dermatitis	6.36e-05	0.00021	CcSEcCtD
Paroxetine—Myalgia—Methylprednisolone—atopic dermatitis	6.36e-05	0.00021	CcSEcCtD
Paroxetine—Eye disorder—Prednisone—atopic dermatitis	6.35e-05	0.000209	CcSEcCtD
Paroxetine—Anxiety—Methylprednisolone—atopic dermatitis	6.34e-05	0.000209	CcSEcCtD
Paroxetine—Tachycardia—Hydrocortisone—atopic dermatitis	6.34e-05	0.000209	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	6.32e-05	0.000208	CcSEcCtD
Paroxetine—Flushing—Prednisone—atopic dermatitis	6.31e-05	0.000208	CcSEcCtD
Paroxetine—Skin disorder—Hydrocortisone—atopic dermatitis	6.31e-05	0.000208	CcSEcCtD
Paroxetine—Ill-defined disorder—Dexamethasone—atopic dermatitis	6.31e-05	0.000208	CcSEcCtD
Paroxetine—Ill-defined disorder—Betamethasone—atopic dermatitis	6.31e-05	0.000208	CcSEcCtD
Paroxetine—Discomfort—Triamcinolone—atopic dermatitis	6.3e-05	0.000207	CcSEcCtD
Paroxetine—Discomfort—Methylprednisolone—atopic dermatitis	6.29e-05	0.000207	CcSEcCtD
Paroxetine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	6.28e-05	0.000207	CcSEcCtD
Paroxetine—Dry mouth—Triamcinolone—atopic dermatitis	6.24e-05	0.000205	CcSEcCtD
Paroxetine—Angioedema—Betamethasone—atopic dermatitis	6.21e-05	0.000205	CcSEcCtD
Paroxetine—Angioedema—Dexamethasone—atopic dermatitis	6.21e-05	0.000205	CcSEcCtD
Paroxetine—Nausea—Tacrolimus—atopic dermatitis	6.18e-05	0.000204	CcSEcCtD
Paroxetine—Angiopathy—Prednisone—atopic dermatitis	6.17e-05	0.000203	CcSEcCtD
Paroxetine—Confusional state—Methylprednisolone—atopic dermatitis	6.15e-05	0.000203	CcSEcCtD
Paroxetine—Immune system disorder—Prednisone—atopic dermatitis	6.14e-05	0.000202	CcSEcCtD
Paroxetine—Malaise—Dexamethasone—atopic dermatitis	6.13e-05	0.000202	CcSEcCtD
Paroxetine—Malaise—Betamethasone—atopic dermatitis	6.13e-05	0.000202	CcSEcCtD
Paroxetine—Anaphylactic shock—Triamcinolone—atopic dermatitis	6.11e-05	0.000201	CcSEcCtD
Paroxetine—Oedema—Triamcinolone—atopic dermatitis	6.11e-05	0.000201	CcSEcCtD
Paroxetine—Vertigo—Dexamethasone—atopic dermatitis	6.11e-05	0.000201	CcSEcCtD
Paroxetine—Vertigo—Betamethasone—atopic dermatitis	6.11e-05	0.000201	CcSEcCtD
Paroxetine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	6.1e-05	0.000201	CcSEcCtD
Paroxetine—Syncope—Betamethasone—atopic dermatitis	6.09e-05	0.000201	CcSEcCtD
Paroxetine—Syncope—Dexamethasone—atopic dermatitis	6.09e-05	0.000201	CcSEcCtD
Paroxetine—Arrhythmia—Prednisone—atopic dermatitis	6.07e-05	0.0002	CcSEcCtD
Paroxetine—Infection—Triamcinolone—atopic dermatitis	6.07e-05	0.0002	CcSEcCtD
Paroxetine—Hypotension—Hydrocortisone—atopic dermatitis	6.07e-05	0.0002	CcSEcCtD
Paroxetine—Infection—Methylprednisolone—atopic dermatitis	6.06e-05	0.0002	CcSEcCtD
Paroxetine—Shock—Triamcinolone—atopic dermatitis	6.01e-05	0.000198	CcSEcCtD
Paroxetine—Insomnia—Prednisolone—atopic dermatitis	6.01e-05	0.000198	CcSEcCtD
Paroxetine—Alopecia—Prednisone—atopic dermatitis	6.01e-05	0.000198	CcSEcCtD
Paroxetine—Shock—Methylprednisolone—atopic dermatitis	6e-05	0.000198	CcSEcCtD
Paroxetine—Nervous system disorder—Methylprednisolone—atopic dermatitis	5.98e-05	0.000197	CcSEcCtD
Paroxetine—Loss of consciousness—Dexamethasone—atopic dermatitis	5.97e-05	0.000197	CcSEcCtD
Paroxetine—Loss of consciousness—Betamethasone—atopic dermatitis	5.97e-05	0.000197	CcSEcCtD
Paroxetine—Paraesthesia—Prednisolone—atopic dermatitis	5.97e-05	0.000197	CcSEcCtD
Paroxetine—Tachycardia—Triamcinolone—atopic dermatitis	5.97e-05	0.000196	CcSEcCtD
Paroxetine—Mental disorder—Prednisone—atopic dermatitis	5.96e-05	0.000196	CcSEcCtD
Paroxetine—Tachycardia—Methylprednisolone—atopic dermatitis	5.95e-05	0.000196	CcSEcCtD
Paroxetine—Skin disorder—Methylprednisolone—atopic dermatitis	5.92e-05	0.000195	CcSEcCtD
Paroxetine—Malnutrition—Prednisone—atopic dermatitis	5.92e-05	0.000195	CcSEcCtD
Paroxetine—Erythema—Prednisone—atopic dermatitis	5.92e-05	0.000195	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	5.91e-05	0.000195	CcSEcCtD
Paroxetine—Hyperhidrosis—Triamcinolone—atopic dermatitis	5.91e-05	0.000195	CcSEcCtD
Paroxetine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	5.9e-05	0.000194	CcSEcCtD
Paroxetine—Convulsion—Betamethasone—atopic dermatitis	5.89e-05	0.000194	CcSEcCtD
Paroxetine—Convulsion—Dexamethasone—atopic dermatitis	5.89e-05	0.000194	CcSEcCtD
Paroxetine—Insomnia—Hydrocortisone—atopic dermatitis	5.87e-05	0.000193	CcSEcCtD
Paroxetine—Hypertension—Dexamethasone—atopic dermatitis	5.87e-05	0.000193	CcSEcCtD
Paroxetine—Hypertension—Betamethasone—atopic dermatitis	5.87e-05	0.000193	CcSEcCtD
Paroxetine—Paraesthesia—Hydrocortisone—atopic dermatitis	5.83e-05	0.000192	CcSEcCtD
Paroxetine—Myalgia—Dexamethasone—atopic dermatitis	5.79e-05	0.000191	CcSEcCtD
Paroxetine—Myalgia—Betamethasone—atopic dermatitis	5.79e-05	0.000191	CcSEcCtD
Paroxetine—Anxiety—Betamethasone—atopic dermatitis	5.77e-05	0.00019	CcSEcCtD
Paroxetine—Anxiety—Dexamethasone—atopic dermatitis	5.77e-05	0.00019	CcSEcCtD
Paroxetine—Discomfort—Dexamethasone—atopic dermatitis	5.72e-05	0.000188	CcSEcCtD
Paroxetine—Discomfort—Betamethasone—atopic dermatitis	5.72e-05	0.000188	CcSEcCtD
Paroxetine—Dyspepsia—Hydrocortisone—atopic dermatitis	5.71e-05	0.000188	CcSEcCtD
Paroxetine—Hypotension—Methylprednisolone—atopic dermatitis	5.7e-05	0.000188	CcSEcCtD
Paroxetine—Pain—Prednisolone—atopic dermatitis	5.68e-05	0.000187	CcSEcCtD
Paroxetine—Decreased appetite—Hydrocortisone—atopic dermatitis	5.64e-05	0.000186	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	5.6e-05	0.000185	CcSEcCtD
Paroxetine—Fatigue—Hydrocortisone—atopic dermatitis	5.6e-05	0.000184	CcSEcCtD
Paroxetine—Vision blurred—Prednisone—atopic dermatitis	5.58e-05	0.000184	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	5.57e-05	0.000183	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	5.56e-05	0.000183	CcSEcCtD
Paroxetine—Pain—Hydrocortisone—atopic dermatitis	5.55e-05	0.000183	CcSEcCtD
Paroxetine—Anaphylactic shock—Betamethasone—atopic dermatitis	5.55e-05	0.000183	CcSEcCtD
Paroxetine—Anaphylactic shock—Dexamethasone—atopic dermatitis	5.55e-05	0.000183	CcSEcCtD
Paroxetine—Oedema—Betamethasone—atopic dermatitis	5.55e-05	0.000183	CcSEcCtD
Paroxetine—Oedema—Dexamethasone—atopic dermatitis	5.55e-05	0.000183	CcSEcCtD
Paroxetine—Insomnia—Triamcinolone—atopic dermatitis	5.53e-05	0.000182	CcSEcCtD
Paroxetine—Insomnia—Methylprednisolone—atopic dermatitis	5.52e-05	0.000182	CcSEcCtD
Paroxetine—Infection—Betamethasone—atopic dermatitis	5.51e-05	0.000181	CcSEcCtD
Paroxetine—Infection—Dexamethasone—atopic dermatitis	5.51e-05	0.000181	CcSEcCtD
Paroxetine—Ill-defined disorder—Prednisone—atopic dermatitis	5.49e-05	0.000181	CcSEcCtD
Paroxetine—Paraesthesia—Triamcinolone—atopic dermatitis	5.49e-05	0.000181	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisolone—atopic dermatitis	5.48e-05	0.00018	CcSEcCtD
Paroxetine—Paraesthesia—Methylprednisolone—atopic dermatitis	5.48e-05	0.00018	CcSEcCtD
Paroxetine—Anaemia—Prednisone—atopic dermatitis	5.47e-05	0.00018	CcSEcCtD
Paroxetine—Shock—Dexamethasone—atopic dermatitis	5.46e-05	0.00018	CcSEcCtD
Paroxetine—Shock—Betamethasone—atopic dermatitis	5.46e-05	0.00018	CcSEcCtD
Paroxetine—Dyspnoea—Triamcinolone—atopic dermatitis	5.45e-05	0.000179	CcSEcCtD
Paroxetine—Nervous system disorder—Dexamethasone—atopic dermatitis	5.44e-05	0.000179	CcSEcCtD
Paroxetine—Nervous system disorder—Betamethasone—atopic dermatitis	5.44e-05	0.000179	CcSEcCtD
Paroxetine—Agitation—Prednisone—atopic dermatitis	5.44e-05	0.000179	CcSEcCtD
Paroxetine—Thrombocytopenia—Betamethasone—atopic dermatitis	5.43e-05	0.000179	CcSEcCtD
Paroxetine—Thrombocytopenia—Dexamethasone—atopic dermatitis	5.43e-05	0.000179	CcSEcCtD
Paroxetine—Tachycardia—Dexamethasone—atopic dermatitis	5.41e-05	0.000178	CcSEcCtD
Paroxetine—Tachycardia—Betamethasone—atopic dermatitis	5.41e-05	0.000178	CcSEcCtD
Paroxetine—Angioedema—Prednisone—atopic dermatitis	5.41e-05	0.000178	CcSEcCtD
Paroxetine—Dyspepsia—Triamcinolone—atopic dermatitis	5.38e-05	0.000177	CcSEcCtD
Paroxetine—Dyspepsia—Methylprednisolone—atopic dermatitis	5.37e-05	0.000177	CcSEcCtD
Paroxetine—Hyperhidrosis—Betamethasone—atopic dermatitis	5.36e-05	0.000177	CcSEcCtD
Paroxetine—Hyperhidrosis—Dexamethasone—atopic dermatitis	5.36e-05	0.000177	CcSEcCtD
Paroxetine—Feeling abnormal—Hydrocortisone—atopic dermatitis	5.35e-05	0.000176	CcSEcCtD
Paroxetine—Malaise—Prednisone—atopic dermatitis	5.34e-05	0.000176	CcSEcCtD
Paroxetine—Vertigo—Prednisone—atopic dermatitis	5.32e-05	0.000175	CcSEcCtD
Paroxetine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	5.31e-05	0.000175	CcSEcCtD
Paroxetine—Syncope—Prednisone—atopic dermatitis	5.31e-05	0.000175	CcSEcCtD
Paroxetine—Urticaria—Prednisolone—atopic dermatitis	5.28e-05	0.000174	CcSEcCtD
Paroxetine—Fatigue—Triamcinolone—atopic dermatitis	5.27e-05	0.000174	CcSEcCtD
Paroxetine—Fatigue—Methylprednisolone—atopic dermatitis	5.26e-05	0.000173	CcSEcCtD
Paroxetine—Pain—Triamcinolone—atopic dermatitis	5.23e-05	0.000172	CcSEcCtD
Paroxetine—Loss of consciousness—Prednisone—atopic dermatitis	5.2e-05	0.000171	CcSEcCtD
Paroxetine—Hypotension—Betamethasone—atopic dermatitis	5.18e-05	0.000171	CcSEcCtD
Paroxetine—Hypotension—Dexamethasone—atopic dermatitis	5.18e-05	0.000171	CcSEcCtD
Paroxetine—Urticaria—Hydrocortisone—atopic dermatitis	5.16e-05	0.00017	CcSEcCtD
Paroxetine—Abdominal pain—Hydrocortisone—atopic dermatitis	5.13e-05	0.000169	CcSEcCtD
Paroxetine—Body temperature increased—Hydrocortisone—atopic dermatitis	5.13e-05	0.000169	CcSEcCtD
Paroxetine—Convulsion—Prednisone—atopic dermatitis	5.13e-05	0.000169	CcSEcCtD
Paroxetine—Hypertension—Prednisone—atopic dermatitis	5.11e-05	0.000168	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	5.05e-05	0.000166	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	5.05e-05	0.000166	CcSEcCtD
Paroxetine—Myalgia—Prednisone—atopic dermatitis	5.04e-05	0.000166	CcSEcCtD
Paroxetine—Arthralgia—Prednisone—atopic dermatitis	5.04e-05	0.000166	CcSEcCtD
Paroxetine—Feeling abnormal—Triamcinolone—atopic dermatitis	5.04e-05	0.000166	CcSEcCtD
Paroxetine—Feeling abnormal—Methylprednisolone—atopic dermatitis	5.03e-05	0.000166	CcSEcCtD
Paroxetine—Anxiety—Prednisone—atopic dermatitis	5.02e-05	0.000165	CcSEcCtD
Paroxetine—Insomnia—Betamethasone—atopic dermatitis	5.02e-05	0.000165	CcSEcCtD
Paroxetine—Insomnia—Dexamethasone—atopic dermatitis	5.02e-05	0.000165	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	5e-05	0.000165	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	4.99e-05	0.000164	CcSEcCtD
Paroxetine—Paraesthesia—Dexamethasone—atopic dermatitis	4.98e-05	0.000164	CcSEcCtD
Paroxetine—Paraesthesia—Betamethasone—atopic dermatitis	4.98e-05	0.000164	CcSEcCtD
Paroxetine—Discomfort—Prednisone—atopic dermatitis	4.98e-05	0.000164	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisolone—atopic dermatitis	4.9e-05	0.000161	CcSEcCtD
Paroxetine—Dyspepsia—Dexamethasone—atopic dermatitis	4.88e-05	0.000161	CcSEcCtD
Paroxetine—Dyspepsia—Betamethasone—atopic dermatitis	4.88e-05	0.000161	CcSEcCtD
Paroxetine—Urticaria—Triamcinolone—atopic dermatitis	4.86e-05	0.00016	CcSEcCtD
Paroxetine—Urticaria—Methylprednisolone—atopic dermatitis	4.85e-05	0.00016	CcSEcCtD
Paroxetine—Body temperature increased—Triamcinolone—atopic dermatitis	4.83e-05	0.000159	CcSEcCtD
Paroxetine—Oedema—Prednisone—atopic dermatitis	4.83e-05	0.000159	CcSEcCtD
Paroxetine—Anaphylactic shock—Prednisone—atopic dermatitis	4.83e-05	0.000159	CcSEcCtD
Paroxetine—Abdominal pain—Methylprednisolone—atopic dermatitis	4.82e-05	0.000159	CcSEcCtD
Paroxetine—Decreased appetite—Dexamethasone—atopic dermatitis	4.82e-05	0.000159	CcSEcCtD
Paroxetine—Decreased appetite—Betamethasone—atopic dermatitis	4.82e-05	0.000159	CcSEcCtD
Paroxetine—Infection—Prednisone—atopic dermatitis	4.8e-05	0.000158	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	4.79e-05	0.000158	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	4.79e-05	0.000158	CcSEcCtD
Paroxetine—Hypersensitivity—Hydrocortisone—atopic dermatitis	4.78e-05	0.000158	CcSEcCtD
Paroxetine—Fatigue—Dexamethasone—atopic dermatitis	4.78e-05	0.000157	CcSEcCtD
Paroxetine—Fatigue—Betamethasone—atopic dermatitis	4.78e-05	0.000157	CcSEcCtD
Paroxetine—Shock—Prednisone—atopic dermatitis	4.75e-05	0.000157	CcSEcCtD
Paroxetine—Pain—Dexamethasone—atopic dermatitis	4.74e-05	0.000156	CcSEcCtD
Paroxetine—Pain—Betamethasone—atopic dermatitis	4.74e-05	0.000156	CcSEcCtD
Paroxetine—Nervous system disorder—Prednisone—atopic dermatitis	4.74e-05	0.000156	CcSEcCtD
Paroxetine—Tachycardia—Prednisone—atopic dermatitis	4.71e-05	0.000155	CcSEcCtD
Paroxetine—Skin disorder—Prednisone—atopic dermatitis	4.69e-05	0.000155	CcSEcCtD
Paroxetine—Hyperhidrosis—Prednisone—atopic dermatitis	4.67e-05	0.000154	CcSEcCtD
Paroxetine—Asthenia—Hydrocortisone—atopic dermatitis	4.66e-05	0.000153	CcSEcCtD
Paroxetine—Pruritus—Hydrocortisone—atopic dermatitis	4.59e-05	0.000151	CcSEcCtD
Paroxetine—Feeling abnormal—Dexamethasone—atopic dermatitis	4.57e-05	0.000151	CcSEcCtD
Paroxetine—Feeling abnormal—Betamethasone—atopic dermatitis	4.57e-05	0.000151	CcSEcCtD
Paroxetine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	4.54e-05	0.000149	CcSEcCtD
Paroxetine—Gastrointestinal pain—Betamethasone—atopic dermatitis	4.54e-05	0.000149	CcSEcCtD
Paroxetine—Hypersensitivity—Triamcinolone—atopic dermatitis	4.5e-05	0.000148	CcSEcCtD
Paroxetine—Hypersensitivity—Methylprednisolone—atopic dermatitis	4.49e-05	0.000148	CcSEcCtD
Paroxetine—Diarrhoea—Hydrocortisone—atopic dermatitis	4.44e-05	0.000146	CcSEcCtD
Paroxetine—Urticaria—Betamethasone—atopic dermatitis	4.41e-05	0.000145	CcSEcCtD
Paroxetine—Urticaria—Dexamethasone—atopic dermatitis	4.41e-05	0.000145	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	4.4e-05	0.000145	CcSEcCtD
Paroxetine—Dizziness—Prednisolone—atopic dermatitis	4.4e-05	0.000145	CcSEcCtD
Paroxetine—Asthenia—Triamcinolone—atopic dermatitis	4.39e-05	0.000144	CcSEcCtD
Paroxetine—Body temperature increased—Dexamethasone—atopic dermatitis	4.38e-05	0.000144	CcSEcCtD
Paroxetine—Body temperature increased—Betamethasone—atopic dermatitis	4.38e-05	0.000144	CcSEcCtD
Paroxetine—Abdominal pain—Dexamethasone—atopic dermatitis	4.38e-05	0.000144	CcSEcCtD
Paroxetine—Abdominal pain—Betamethasone—atopic dermatitis	4.38e-05	0.000144	CcSEcCtD
Paroxetine—Asthenia—Methylprednisolone—atopic dermatitis	4.38e-05	0.000144	CcSEcCtD
Paroxetine—Insomnia—Prednisone—atopic dermatitis	4.37e-05	0.000144	CcSEcCtD
Paroxetine—Paraesthesia—Prednisone—atopic dermatitis	4.34e-05	0.000143	CcSEcCtD
Paroxetine—Pruritus—Triamcinolone—atopic dermatitis	4.32e-05	0.000142	CcSEcCtD
Paroxetine—Pruritus—Methylprednisolone—atopic dermatitis	4.32e-05	0.000142	CcSEcCtD
Paroxetine—Dizziness—Hydrocortisone—atopic dermatitis	4.29e-05	0.000141	CcSEcCtD
Paroxetine—Dyspepsia—Prednisone—atopic dermatitis	4.25e-05	0.00014	CcSEcCtD
Paroxetine—Decreased appetite—Prednisone—atopic dermatitis	4.2e-05	0.000138	CcSEcCtD
Paroxetine—Rash—Prednisolone—atopic dermatitis	4.19e-05	0.000138	CcSEcCtD
Paroxetine—Dermatitis—Prednisolone—atopic dermatitis	4.19e-05	0.000138	CcSEcCtD
Paroxetine—Diarrhoea—Methylprednisolone—atopic dermatitis	4.17e-05	0.000137	CcSEcCtD
Paroxetine—Fatigue—Prednisone—atopic dermatitis	4.16e-05	0.000137	CcSEcCtD
Paroxetine—Headache—Prednisolone—atopic dermatitis	4.16e-05	0.000137	CcSEcCtD
Paroxetine—Constipation—Prednisone—atopic dermatitis	4.13e-05	0.000136	CcSEcCtD
Paroxetine—Vomiting—Hydrocortisone—atopic dermatitis	4.13e-05	0.000136	CcSEcCtD
Paroxetine—Rash—Hydrocortisone—atopic dermatitis	4.09e-05	0.000135	CcSEcCtD
Paroxetine—Dermatitis—Hydrocortisone—atopic dermatitis	4.09e-05	0.000135	CcSEcCtD
Paroxetine—Headache—Hydrocortisone—atopic dermatitis	4.07e-05	0.000134	CcSEcCtD
Paroxetine—Dizziness—Triamcinolone—atopic dermatitis	4.04e-05	0.000133	CcSEcCtD
Paroxetine—Dizziness—Methylprednisolone—atopic dermatitis	4.03e-05	0.000133	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisone—atopic dermatitis	3.98e-05	0.000131	CcSEcCtD
Paroxetine—Asthenia—Dexamethasone—atopic dermatitis	3.98e-05	0.000131	CcSEcCtD
Paroxetine—Asthenia—Betamethasone—atopic dermatitis	3.98e-05	0.000131	CcSEcCtD
Paroxetine—Gastrointestinal pain—Prednisone—atopic dermatitis	3.95e-05	0.00013	CcSEcCtD
Paroxetine—Nausea—Prednisolone—atopic dermatitis	3.95e-05	0.00013	CcSEcCtD
Paroxetine—Pruritus—Betamethasone—atopic dermatitis	3.92e-05	0.000129	CcSEcCtD
Paroxetine—Pruritus—Dexamethasone—atopic dermatitis	3.92e-05	0.000129	CcSEcCtD
Paroxetine—Vomiting—Triamcinolone—atopic dermatitis	3.89e-05	0.000128	CcSEcCtD
Paroxetine—Vomiting—Methylprednisolone—atopic dermatitis	3.88e-05	0.000128	CcSEcCtD
Paroxetine—Nausea—Hydrocortisone—atopic dermatitis	3.86e-05	0.000127	CcSEcCtD
Paroxetine—Rash—Triamcinolone—atopic dermatitis	3.85e-05	0.000127	CcSEcCtD
Paroxetine—Dermatitis—Triamcinolone—atopic dermatitis	3.85e-05	0.000127	CcSEcCtD
Paroxetine—Rash—Methylprednisolone—atopic dermatitis	3.85e-05	0.000127	CcSEcCtD
Paroxetine—Dermatitis—Methylprednisolone—atopic dermatitis	3.84e-05	0.000127	CcSEcCtD
Paroxetine—Urticaria—Prednisone—atopic dermatitis	3.84e-05	0.000126	CcSEcCtD
Paroxetine—Headache—Triamcinolone—atopic dermatitis	3.83e-05	0.000126	CcSEcCtD
Paroxetine—Headache—Methylprednisolone—atopic dermatitis	3.82e-05	0.000126	CcSEcCtD
Paroxetine—Body temperature increased—Prednisone—atopic dermatitis	3.82e-05	0.000126	CcSEcCtD
Paroxetine—Abdominal pain—Prednisone—atopic dermatitis	3.82e-05	0.000126	CcSEcCtD
Paroxetine—Diarrhoea—Dexamethasone—atopic dermatitis	3.79e-05	0.000125	CcSEcCtD
Paroxetine—Diarrhoea—Betamethasone—atopic dermatitis	3.79e-05	0.000125	CcSEcCtD
Paroxetine—Dizziness—Dexamethasone—atopic dermatitis	3.67e-05	0.000121	CcSEcCtD
Paroxetine—Dizziness—Betamethasone—atopic dermatitis	3.67e-05	0.000121	CcSEcCtD
Paroxetine—Nausea—Triamcinolone—atopic dermatitis	3.63e-05	0.00012	CcSEcCtD
Paroxetine—Nausea—Methylprednisolone—atopic dermatitis	3.62e-05	0.000119	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisone—atopic dermatitis	3.56e-05	0.000117	CcSEcCtD
Paroxetine—Vomiting—Dexamethasone—atopic dermatitis	3.53e-05	0.000116	CcSEcCtD
Paroxetine—Vomiting—Betamethasone—atopic dermatitis	3.53e-05	0.000116	CcSEcCtD
Paroxetine—Rash—Betamethasone—atopic dermatitis	3.5e-05	0.000115	CcSEcCtD
Paroxetine—Rash—Dexamethasone—atopic dermatitis	3.5e-05	0.000115	CcSEcCtD
Paroxetine—CHRM5—Signaling by GPCR—CXCL10—atopic dermatitis	3.49e-05	0.000503	CbGpPWpGaD
Paroxetine—Dermatitis—Betamethasone—atopic dermatitis	3.49e-05	0.000115	CcSEcCtD
Paroxetine—Dermatitis—Dexamethasone—atopic dermatitis	3.49e-05	0.000115	CcSEcCtD
Paroxetine—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	3.49e-05	0.000503	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	3.48e-05	0.000502	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	3.48e-05	0.000501	CbGpPWpGaD
Paroxetine—Headache—Betamethasone—atopic dermatitis	3.47e-05	0.000114	CcSEcCtD
Paroxetine—Headache—Dexamethasone—atopic dermatitis	3.47e-05	0.000114	CcSEcCtD
Paroxetine—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	3.47e-05	0.0005	CbGpPWpGaD
Paroxetine—Asthenia—Prednisone—atopic dermatitis	3.47e-05	0.000114	CcSEcCtD
Paroxetine—CHRM4—GPCR downstream signaling—CCL5—atopic dermatitis	3.46e-05	0.000498	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	3.45e-05	0.000496	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	3.44e-05	0.000495	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—NPS—atopic dermatitis	3.44e-05	0.000495	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—TAC1—atopic dermatitis	3.44e-05	0.000495	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	3.42e-05	0.000492	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	3.42e-05	0.000492	CbGpPWpGaD
Paroxetine—Pruritus—Prednisone—atopic dermatitis	3.42e-05	0.000113	CcSEcCtD
Paroxetine—CYP2B6—Metabolism—GLB1—atopic dermatitis	3.42e-05	0.000492	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	3.41e-05	0.000491	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	3.41e-05	0.000491	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	3.37e-05	0.000486	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	3.37e-05	0.000486	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CXCR3—atopic dermatitis	3.37e-05	0.000485	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—STAT6—atopic dermatitis	3.37e-05	0.000485	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	3.35e-05	0.000483	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	3.34e-05	0.000481	CbGpPWpGaD
Paroxetine—CHRM4—GPCR ligand binding—CXCL8—atopic dermatitis	3.33e-05	0.00048	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—CCL5—atopic dermatitis	3.31e-05	0.000477	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	3.31e-05	0.000477	CbGpPWpGaD
Paroxetine—Diarrhoea—Prednisone—atopic dermatitis	3.3e-05	0.000109	CcSEcCtD
Paroxetine—Nausea—Betamethasone—atopic dermatitis	3.29e-05	0.000109	CcSEcCtD
Paroxetine—Nausea—Dexamethasone—atopic dermatitis	3.29e-05	0.000109	CcSEcCtD
Paroxetine—CYP2B6—Metabolism—ADSL—atopic dermatitis	3.27e-05	0.000472	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL5—atopic dermatitis	3.19e-05	0.00046	CbGpPWpGaD
Paroxetine—Dizziness—Prednisone—atopic dermatitis	3.19e-05	0.000105	CcSEcCtD
Paroxetine—CHRM5—GPCR ligand binding—CXCL8—atopic dermatitis	3.19e-05	0.00046	CbGpPWpGaD
Paroxetine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.18e-05	0.000458	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	3.18e-05	0.000458	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	3.17e-05	0.000456	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCL17—atopic dermatitis	3.15e-05	0.000453	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—CCL5—atopic dermatitis	3.14e-05	0.000452	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	3.14e-05	0.000452	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	3.13e-05	0.000451	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	3.12e-05	0.000449	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—NPS—atopic dermatitis	3.12e-05	0.000449	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—TAC1—atopic dermatitis	3.12e-05	0.000449	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—CCR5—atopic dermatitis	3.12e-05	0.000449	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	3.1e-05	0.000447	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	3.1e-05	0.000447	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	3.09e-05	0.000446	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	3.09e-05	0.000446	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	3.09e-05	0.000445	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—NFKBIA—atopic dermatitis	3.09e-05	0.000445	CbGpPWpGaD
Paroxetine—Vomiting—Prednisone—atopic dermatitis	3.07e-05	0.000101	CcSEcCtD
Paroxetine—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	3.06e-05	0.000441	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	3.06e-05	0.000441	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CXCR3—atopic dermatitis	3.06e-05	0.000441	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CCR3—atopic dermatitis	3.05e-05	0.000439	CbGpPWpGaD
Paroxetine—Rash—Prednisone—atopic dermatitis	3.05e-05	0.0001	CcSEcCtD
Paroxetine—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	3.04e-05	0.000438	CbGpPWpGaD
Paroxetine—Dermatitis—Prednisone—atopic dermatitis	3.04e-05	0.0001	CcSEcCtD
Paroxetine—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	3.03e-05	0.000437	CbGpPWpGaD
Paroxetine—Headache—Prednisone—atopic dermatitis	3.03e-05	9.97e-05	CcSEcCtD
Paroxetine—CHRM5—Signaling by GPCR—CCL5—atopic dermatitis	3.01e-05	0.000433	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	3e-05	0.000433	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—CCR5—atopic dermatitis	2.98e-05	0.00043	CbGpPWpGaD
Paroxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.97e-05	0.000427	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.95e-05	0.000425	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.94e-05	0.000424	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CCR3—atopic dermatitis	2.92e-05	0.000421	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.91e-05	0.00042	CbGpPWpGaD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.91e-05	0.000419	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL5—atopic dermatitis	2.9e-05	0.000418	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GLB1—atopic dermatitis	2.89e-05	0.000416	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	2.89e-05	0.000416	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	2.88e-05	0.000414	CbGpPWpGaD
Paroxetine—Nausea—Prednisone—atopic dermatitis	2.87e-05	9.45e-05	CcSEcCtD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.86e-05	0.000411	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	2.85e-05	0.00041	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—CCR5—atopic dermatitis	2.83e-05	0.000408	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—KIF3A—atopic dermatitis	2.81e-05	0.000404	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	2.79e-05	0.000402	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	2.78e-05	0.000401	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ADSL—atopic dermatitis	2.77e-05	0.000399	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	2.75e-05	0.000397	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CXCL10—atopic dermatitis	2.72e-05	0.000392	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TAC1—atopic dermatitis	2.72e-05	0.000392	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NPS—atopic dermatitis	2.72e-05	0.000392	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—CCR5—atopic dermatitis	2.71e-05	0.00039	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	2.71e-05	0.00039	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	2.7e-05	0.000389	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	2.67e-05	0.000385	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CXCR3—atopic dermatitis	2.67e-05	0.000384	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NPS—atopic dermatitis	2.6e-05	0.000375	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TAC1—atopic dermatitis	2.6e-05	0.000375	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CXCR3—atopic dermatitis	2.55e-05	0.000368	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCL11—atopic dermatitis	2.54e-05	0.000365	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CMA1—atopic dermatitis	2.54e-05	0.000365	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL5—atopic dermatitis	2.53e-05	0.000364	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	2.52e-05	0.000363	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	2.52e-05	0.000363	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GLB1—atopic dermatitis	2.52e-05	0.000363	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	2.52e-05	0.000362	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	2.52e-05	0.000362	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	2.49e-05	0.000359	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	2.49e-05	0.000359	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CXCL10—atopic dermatitis	2.47e-05	0.000356	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	2.46e-05	0.000354	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	2.45e-05	0.000353	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.44e-05	0.000351	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	2.43e-05	0.00035	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL5—atopic dermatitis	2.42e-05	0.000349	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ADSL—atopic dermatitis	2.41e-05	0.000348	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—STAT6—atopic dermatitis	2.39e-05	0.000344	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GLB1—atopic dermatitis	2.37e-05	0.000342	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	2.37e-05	0.000342	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	2.37e-05	0.000341	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	2.36e-05	0.00034	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GLB1—atopic dermatitis	2.35e-05	0.000339	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CCL5—atopic dermatitis	2.34e-05	0.000338	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	2.34e-05	0.000337	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	2.33e-05	0.000336	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	2.33e-05	0.000335	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	2.3e-05	0.000332	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ADSL—atopic dermatitis	2.28e-05	0.000328	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—CXCL8—atopic dermatitis	2.26e-05	0.000325	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ADSL—atopic dermatitis	2.26e-05	0.000325	CbGpPWpGaD
Paroxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.25e-05	0.000324	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	2.25e-05	0.000324	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	2.24e-05	0.000323	CbGpPWpGaD
Paroxetine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.24e-05	0.000323	CbGpPWpGaD
Paroxetine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.23e-05	0.000321	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	2.22e-05	0.00032	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CXCL8—atopic dermatitis	2.2e-05	0.000317	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CXCL10—atopic dermatitis	2.16e-05	0.00031	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CCL5—atopic dermatitis	2.13e-05	0.000307	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	2.12e-05	0.000305	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CCR5—atopic dermatitis	2.11e-05	0.000304	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	2.11e-05	0.000304	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.11e-05	0.000303	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL2—atopic dermatitis	2.1e-05	0.000303	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	2.1e-05	0.000303	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	2.09e-05	0.000302	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—IL6—atopic dermatitis	2.09e-05	0.000301	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	2.09e-05	0.000301	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	2.07e-05	0.000299	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCR3—atopic dermatitis	2.07e-05	0.000298	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CXCL10—atopic dermatitis	2.06e-05	0.000297	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	2.06e-05	0.000296	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	2.05e-05	0.000295	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	2.03e-05	0.000292	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—MAPK8—atopic dermatitis	1.94e-05	0.000279	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.93e-05	0.000278	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	1.92e-05	0.000276	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	1.91e-05	0.000275	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	1.9e-05	0.000274	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	1.88e-05	0.000271	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	1.88e-05	0.000271	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	1.86e-05	0.000267	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	1.84e-05	0.000265	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NPS—atopic dermatitis	1.84e-05	0.000265	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	1.83e-05	0.000264	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NPS—atopic dermatitis	1.83e-05	0.000264	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	1.83e-05	0.000263	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NPS—atopic dermatitis	1.83e-05	0.000263	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NPS—atopic dermatitis	1.81e-05	0.000261	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	1.81e-05	0.000261	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	1.81e-05	0.00026	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	1.8e-05	0.00026	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	1.8e-05	0.000259	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	1.8e-05	0.000259	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	1.79e-05	0.000258	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	1.78e-05	0.000256	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	1.78e-05	0.000256	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.75e-05	0.000251	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	1.72e-05	0.000248	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NGF—atopic dermatitis	1.72e-05	0.000247	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.71e-05	0.000247	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL5—atopic dermatitis	1.71e-05	0.000247	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	1.71e-05	0.000246	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL5—atopic dermatitis	1.7e-05	0.000245	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL5—atopic dermatitis	1.7e-05	0.000245	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL5—atopic dermatitis	1.68e-05	0.000242	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	1.67e-05	0.000241	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NGF—atopic dermatitis	1.65e-05	0.000237	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	1.64e-05	0.000236	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	1.64e-05	0.000235	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	1.6e-05	0.000231	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	1.57e-05	0.000225	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	1.46e-05	0.00021	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	1.45e-05	0.000209	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	1.45e-05	0.000209	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	1.43e-05	0.000207	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	1.42e-05	0.000204	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	1.36e-05	0.000195	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PPARA—atopic dermatitis	1.29e-05	0.000186	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.28e-05	0.000184	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.27e-05	0.000183	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.27e-05	0.000182	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	1.26e-05	0.000181	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.25e-05	0.000181	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	1.25e-05	0.00018	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	1.25e-05	0.00018	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL6—atopic dermatitis	1.24e-05	0.000178	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	1.24e-05	0.000178	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	1.22e-05	0.000176	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	1.21e-05	0.000175	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	1.21e-05	0.000174	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	1.2e-05	0.000173	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NGF—atopic dermatitis	1.17e-05	0.000168	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	1.16e-05	0.000167	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NGF—atopic dermatitis	1.16e-05	0.000167	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NGF—atopic dermatitis	1.16e-05	0.000166	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	1.15e-05	0.000166	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	1.15e-05	0.000166	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NGF—atopic dermatitis	1.14e-05	0.000165	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	1.14e-05	0.000164	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	1.13e-05	0.000163	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	1.13e-05	0.000162	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	1.12e-05	0.000162	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	1.11e-05	0.00016	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	1.11e-05	0.00016	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PPARA—atopic dermatitis	1.11e-05	0.00016	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	1.1e-05	0.000159	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	1.1e-05	0.000158	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	1.09e-05	0.000157	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	1.01e-05	0.000146	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	9.68e-06	0.000139	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL2—atopic dermatitis	9.66e-06	0.000139	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	9.61e-06	0.000138	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	9.61e-06	0.000138	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	9.56e-06	0.000138	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	9.53e-06	0.000137	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	9.43e-06	0.000136	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PPARA—atopic dermatitis	9.38e-06	0.000135	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL2—atopic dermatitis	9.25e-06	0.000133	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	9.2e-06	0.000133	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	8.89e-06	0.000128	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	8.51e-06	0.000123	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PPARA—atopic dermatitis	8.17e-06	0.000118	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPARA—atopic dermatitis	7.7e-06	0.000111	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPARA—atopic dermatitis	7.64e-06	0.00011	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	6.85e-06	9.87e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	6.82e-06	9.81e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	6.79e-06	9.78e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	6.73e-06	9.69e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2—atopic dermatitis	6.55e-06	9.43e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	6.52e-06	9.38e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2—atopic dermatitis	6.51e-06	9.38e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2—atopic dermatitis	6.49e-06	9.35e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	6.48e-06	9.33e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	6.46e-06	9.3e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2—atopic dermatitis	6.43e-06	9.26e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	6.4e-06	9.21e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	6.03e-06	8.68e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	5.99e-06	8.63e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	5.98e-06	8.61e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	5.92e-06	8.52e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6—atopic dermatitis	5.68e-06	8.18e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6—atopic dermatitis	5.44e-06	7.83e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6—atopic dermatitis	3.85e-06	5.54e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6—atopic dermatitis	3.83e-06	5.51e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6—atopic dermatitis	3.82e-06	5.5e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6—atopic dermatitis	3.78e-06	5.44e-05	CbGpPWpGaD
